Want to see TSE:EDT full AI Analyst Report?
Total Valuation
Spectral Medical has a market cap or net worth of C$390.43M. The enterprise value is C$411.25.
Market CapC$390.43M
Enterprise ValueC$411.25
Share Statistics
Spectral Medical has 293,554,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding293,554,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Spectral Medical’s return on equity (ROE) is 0.68 and return on invested capital (ROIC) is 26.80%.
Return on Equity (ROE)0.68
Return on Assets (ROA)-7.82
Return on Invested Capital (ROIC)26.80%
Return on Capital Employed (ROCE)0.19
Revenue Per Employee84.21K
Profits Per Employee-1.64M
Employee Count29
Asset Turnover0.40
Inventory Turnover20.15
Valuation Ratios
The current PE Ratio of Spectral Medical is ―. Spectral Medical’s PEG ratio is -0.04.
PE Ratio―
PS Ratio169.36
PB Ratio-5.93
Price to Fair Value-5.93
Price to FCF-42.55
Price to Operating Cash Flow-37.31
PEG Ratio-0.04
Income Statement
In the last 12 months, Spectral Medical had revenue of 2.44M and earned -47.69M in profits. Earnings per share was -0.17.
Revenue2.44M
Gross Profit-5.16M
Operating Income-11.69M
Pretax Income-47.69M
Net Income-47.69M
EBITDA-42.27M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was -10.46M and capital expenditures -28.00K, giving a free cash flow of -10.49M billion.
Operating Cash Flow-10.46M
Free Cash Flow-10.49M
Free Cash Flow per Share-0.04
Dividends & Yields
Spectral Medical pays an annual dividend of C$0.12, resulting in a dividend yield of ―
Dividend Per ShareC$0.12
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.85
52-Week Price Change-15.29%
50-Day Moving Average1.36
200-Day Moving Average1.36
Relative Strength Index (RSI)42.10
Average Volume (3m)78.93K
Important Dates
Spectral Medical upcoming earnings date is Nov 6, 2026, TBA (Confirmed).
Last Earnings DateAug 7, 2026
Next Earnings DateNov 6, 2026
Ex-Dividend Date―
Financial Position
Spectral Medical as a current ratio of 0.08, with Debt / Equity ratio of -36.65%
Current Ratio0.08
Quick Ratio0.07
Debt to Market Cap0.05
Net Debt to EBITDA-0.40
Interest Coverage Ratio-2.26
Taxes
In the past 12 months, Spectral Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Spectral Medical EV to EBITDA ratio is -10.19, with an EV/FCF ratio of -44.30.
EV to Sales176.33
EV to EBITDA-10.19
EV to Free Cash Flow-44.30
EV to Operating Cash Flow-45.21
Balance Sheet
Spectral Medical has C$803.00K in cash and marketable securities with C$25.68M in debt, giving a net cash position of -C$24.88M billion.
Cash & Marketable SecuritiesC$803.00K
Total DebtC$25.68M
Net Cash-C$24.88M
Net Cash Per Share-C$0.08
Tangible Book Value Per Share-C$0.24
Margins
Gross margin is -94.78%, with operating margin of -478.50%, and net profit margin of -1952.99%.
Gross Margin-94.78%
Operating Margin-478.50%
Pretax Margin-1952.87%
Net Profit Margin-1952.99%
EBITDA Margin-1731.16%
EBIT Margin-1741.40%
Analyst Forecast
The average price target for Spectral Medical is C$3.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$3.50
Price Target Upside163.16% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast1.46%
EPS Growth Forecast-64.85%